RNA editing is the next frontier in gene therapy—here's what you need to know
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...
Interesting Engineering1d
NYU performs world’s first fully robotic double lung transplant in medical milestone
NYU Langone performs the world’s first fully robotic double lung transplant, marking a breakthrough in minimally invasive ...
FierceBiotech1d
Illumina previews updated tumor research assay, begins shipping IVD kits
Illumina raised the curtain on a revamp of its flagship tumor profiling test, which aims to offer faster turnarounds, fewer ...
Targeted Oncology1d
Future Treatment Landscape for EGFR-mutated Non-Small Cell Lung Cancer
Panelist discusses how the future treatment landscape for EGFR-mutant advanced non–small cell lung cancer is evolving to address current unmet needs and offers clinical pearls to community oncologists ...
Woman receives world's first robotic double-lung transplant
A 57-year-old woman with COPD has received the world's first fully robotic double lung transplant. The breakthrough surgery ...
Le Lézard5d
Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung Cancer (SCLC)
Novotech, the global full-service clinical Contract Research Organization (CRO), has published a new report, Small Cell Lung Cancer: Global Clinical Trial Landscape 2024, providing an in-depth ...
Pharmabiz6d
EMA committee recommends approval of Bristol Myers’ repotrectinib to treat advanced ROS1-positive NSCLC & NTRK-positive solid tumours
EMA committee recommends approval of Bristol Myers’ repotrectinib to treat advanced ROS1-positive NSCLC & NTRK-positive solid tumours: Princeton, New Jersey Monday, November 18, ...